These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756 [TBL] [Abstract][Full Text] [Related]
24. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer. Kitagawa R; Katsumata N; Ando M; Shimizu C; Fujiwara Y; Yoshikawa H; Satoh T; Nakanishi T; Ushijima K; Kamura T Gynecol Oncol; 2012 May; 125(2):307-11. PubMed ID: 22333993 [TBL] [Abstract][Full Text] [Related]
25. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer. Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422 [TBL] [Abstract][Full Text] [Related]
26. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO. Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ; J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940 [TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer]. Misawa A; Nagao M; Kushimoto T; Yasuda M Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339 [TBL] [Abstract][Full Text] [Related]
28. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC). Giorgio CG; Pappalardo A; Russo A; Giuffrida D; Santini D; Petralia G; Castorina S; Nunzio R; Failla G; Bordonaro R Lung Cancer; 2006 Mar; 51(3):357-62. PubMed ID: 16406602 [TBL] [Abstract][Full Text] [Related]
29. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601 [TBL] [Abstract][Full Text] [Related]
30. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer. Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567 [TBL] [Abstract][Full Text] [Related]
31. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group. Pignata S; Scambia G; Pisano C; Breda E; Di Maio M; Greggi S; Ferrandina G; Lorusso D; Zagonel V; Febbraro A; Riva N; De Rosa V; Gallo C; Perrone F; Br J Cancer; 2007 Jun; 96(11):1639-43. PubMed ID: 17486128 [TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours. Harries M; O'Donnell A; Scurr M; Reade S; Cole C; Judson I; Greystoke A; Twelves C; Kaye S Br J Cancer; 2004 Nov; 91(9):1651-5. PubMed ID: 15494716 [TBL] [Abstract][Full Text] [Related]
33. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838 [TBL] [Abstract][Full Text] [Related]
34. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer. Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570 [TBL] [Abstract][Full Text] [Related]
35. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut). du Bois A; Pfisterer J; Burchardi N; Loibl S; Huober J; Wimberger P; Burges A; Stähle A; Jackisch C; Kölbl H; ; Gynecol Oncol; 2007 Dec; 107(3):518-25. PubMed ID: 17910981 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. Torfs S; Cadron I; Amant F; Leunen K; Berteloot P; Vergote I Eur J Cancer; 2012 Jun; 48(9):1332-40. PubMed ID: 22317951 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma. Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327 [TBL] [Abstract][Full Text] [Related]
38. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318 [TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and carboplatin in pretreated advanced gastric cancer: a phase II study. Stathopoulos GP; Rigatos SK; Fountzilas G; Polyzos A; Stathopoulos JG Oncol Rep; 2002; 9(1):89-92. PubMed ID: 11748462 [TBL] [Abstract][Full Text] [Related]
40. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study. Piver MS; Ghamande SA; Eltabbakh GH; O'Neill-Coppola C Gynecol Oncol; 1999 Dec; 75(3):334-7. PubMed ID: 10600285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]